RIPK1 degradation with R1-ICR-3 treatment prevented RIPK3, especially activated RIPK3 (pRIPK3), from binding to ZBP1 during HSV-1(ICP6mut) infections (Fig 3E). Here, ZBP1 is linked to infection.